Alkermes (ALKS) Tops Q4 EPS by 2c; Issues Strong FY13 EPS Outlook
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $46.10 -1.66%
Revenue Growth %: +17.7%
Financial Fact:
INCOME TAX BENEFIT: -880K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +17.7%
Financial Fact:
INCOME TAX BENEFIT: -880K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q4 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $130.5 million versus the consensus estimate of $125.88 million.
Alkermes sees FY2013 EPS of $0.62-$0.77, versus the consensus of $-0.29. Alkermes sees FY2013 revenue of $490-$530 million, versus the consensus of $522.94 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Alkermes sees FY2013 EPS of $0.62-$0.77, versus the consensus of $-0.29. Alkermes sees FY2013 revenue of $490-$530 million, versus the consensus of $522.94 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
